Stock listing

Anavex Life Sciences Corp.

Selected listing: 12X1 · DUS · EUR · DE

Anavex Life Sciences Corp. (Dusseldorf:12X1), Health Technology. Latest release Sep 18, 2026: PVG Asset Management Announces Plan for First 100 Days at Anavex…

12X1:DUSEURDEUpdated October 2, 2026
Anavex Life Sciences Corp. logo
Ticker
Dusseldorf:12X1
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
Dusseldorf
Currency
EUR

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. (AVXL) is a public company based in the United States, focusing on the development of therapies for neurodegenerative diseases. The company aims to address significant unmet medical needs in the field of neuroscience.

Latest news from Anavex Life Sciences Corp.

All Anavex Life Sciences Corp. news →

Events

Replays

  • Anavex Life Sciences Corp. (AVXL) Q1 2026 Earnings Call

    Mon, Feb 09, 2026 · 08:30 AM ET

    Watch
  • Anavex Life Sciences Corp. (AVXL) Q4 2025 Earnings Call

    Tue, Nov 25, 2025 · 08:30 AM ET

    Watch
  • Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call

    Tue, Aug 12, 2025 · 08:30 AM ET

    Watch

Research Anavex Life Sciences Corp.

Alternate listings